|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-12-12
|
|
pubmed:abstractText |
The beneficial effects of ACE inhibitors are generally ascribed to blockade of neurohormonal activation. However, especially in chronic heart failure (CHF) patients plasma angiotensin II and aldosterone levels can be elevated despite ACE inhibition, the so-called ACE escape. In the present study, we aimed to identify the frequency and determinants of ACE escape in CHF patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0167-5273
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
106
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
367-72
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16337046-Aged,
pubmed-meshheading:16337046-Aged, 80 and over,
pubmed-meshheading:16337046-Aldosterone Antagonists,
pubmed-meshheading:16337046-Angiotensin I,
pubmed-meshheading:16337046-Angiotensin II,
pubmed-meshheading:16337046-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:16337046-Feedback, Physiological,
pubmed-meshheading:16337046-Female,
pubmed-meshheading:16337046-Heart Failure,
pubmed-meshheading:16337046-Humans,
pubmed-meshheading:16337046-Male,
pubmed-meshheading:16337046-Middle Aged,
pubmed-meshheading:16337046-Peptidyl-Dipeptidase A,
pubmed-meshheading:16337046-Renin,
pubmed-meshheading:16337046-Renin-Angiotensin System,
pubmed-meshheading:16337046-Spironolactone
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
|
|
pubmed:affiliation |
Department of Cardiology, St. Antonius Hospital, Koekoekslaan 1, PO Box 2500, 3435 CM Nieuwegein, The Netherlands. r.wal@antonius.net
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
